Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
What made us buy IEX@193, Tata Power@56, Titan@330, Divis@629, Persistent@700.
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Link Pharma Chem Ltd Stock Analysis

Small Cap
Evaluated by 130 users | BSE: 524748 | NSE: |
Pharmaceuticals & Drugs

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on Capital Employed 9.08%4.45%6.67%6.46%6.76%-6.12%-3.59%8.2%12.1%6.99%12.46%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 11.113.317.516.423.617.612.316.123.524.525.549
Y-o-Y Gr. Rt.-19.7%31.8%-6.6%44.2%-25.5%-29.8%30.5%46.2%4.1%4%-
Adjusted EPS (Rs.) 20.511.120.651.16-4.94-2.791.32.551.43.363.15
Y-o-Y Gr. Rt.--74.5%119.6%-42%78.5%-525.9%NANA96.2%-45.1%140%-
Book Value per Share (Rs.) 20.5521.0722.2122.8624.0218.8520.1819.3722.0523.3825.7530.38
Adjusted Net Profit 0.90.20.50.30.5-2.2-1.20.61.10.61.51
Net Op. Cash Flow (Rs. Cr.) 1.3-1.83-0.80.95.1-3.92.23.81.43-
Debt to Cash Flow from Ops 4.11-4.322.03-10.5910.372.11-1.382.120.721.941.2-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Link Pharma Chem Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales 7.5%7.7%16.5%4%
Adjusted EPS 23.3%NA37.2%140%
Book Value per Share 2.36.41010.1
Share Price 20.3% 25.3% 9.8% 47.2%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on Equity (%) 10.232.475.162.884.97-23.07-14.296.5612.316.1713.6811.22
Operating Profit Margin (%) 15.170.9210.0213.229.91-4.47-1.2915.7811.88.2413.526.98
Net Profit Margin (%) 8.011.722.831.762.19-12.49-10.033.584.812.545.862.83
Debt to Equity 0.590.830.620.880.851.290.60.550.280.250.310.29
Working Capital Days 20018414817313516420014811111511779
Cash Conversion Cycle 5581709371771197632353543
Loading price chart...
Entity Percentage Holding
Promoters 51.49%
Institutions 0.02%
Non-Institutions 48.49%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Link Pharma Chem Ltd's earnings have grown by 0%, whereas share price has appreciated 25.3% CAGR over the past five years, indicating the company’s share price is likely overvalued. However, for specific investment actions please consult your investment advisor.

Link Pharma Chem Ltd share price has appreciated 20.3% annually (CAGR) over the past ten years.

Data is not available for this company.

Link Pharma Chem, incorporated on December 28, 1984 is a manufacturer of thionyl chloride.

The company manufactures thionyl chloride and other inorganic chemical intermediates at its plants located in the Baroda and Ankleshwar districts of Gujarat with an installed capacity of 2,100 TPA. In FY08, the company received an international grant from United Nations Industrial Development Organization of Rs 7.7 million for phasing out a carbon tetra chloride product as raw material, which was

Link Pharma Chem, incorporated on December 28, 1984 is a manufacturer of thionyl chloride.

The company manufactures thionyl chloride and other inorganic chemical intermediates at its plants located in the Baroda and Ankleshwar districts of Gujarat with an installed capacity of 2,100 TPA. In FY08, the company received an international grant from United Nations Industrial Development Organization of Rs 7.7 million for phasing out a carbon tetra chloride product as raw material, which was implemented. The company plans to develop the acquired land in the Baroda district and has purchased a 10,800 sq. m. plot with RCC building of approximately 50,000 sq. ft. constructed area from DRT Ahmedabad for Rs 14 million for diversification projects.

Link Pharma Chem has, over the years, followed the best business practices. The company believes that good corporate governance is essential to achieve long-term corporate goals and to enhance stakeholders' value. In this pursuit, the company is committed to conducting business in accordance with the highest legal and ethical standard, superior product quality and services to its customers. All employees are bound by a code of conduct, which sets forth the company's policies on important issues, including relationship with customers, vendors and the government.

Business areas of the company:

The company manufactures thionyl chloride and other inorganic chemical intermediates at its plants located in the Baroda and Ankleshwar districts of Gujarat with an installed capacity of 2,100 TPA.

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback